Transit Scientific is a dynamic medical device company that focuses on developing innovative solutions for unmet needs in the cardiovascular and vascular fields. With a patient-first approach, the company prioritizes safety and clinical efficacy as the keys to its product success. Built on a foundation of breakthrough technology, Transit Scientific boasts an impressive portfolio of 14 issued/allowed patents, with an additional 14 patents pending.

Established in 2016, Transit Scientific is headquartered in Park City, Utah, and operates with a core team and engineering resources based in Salt Lake City, Utah. The company collaborates with US-based ISO 13485 vendors for its manufacturing and quality needs. What sets Transit Scientific apart is its esteemed team of experienced medical device entrepreneurs, actively contributing to its overall success through their involvement on the board, as co-founders, venture partners, advisors, and IP contributors.

With a dedicated and accomplished management team, including President & CEO Greg Method at the helm, Transit Scientific is paving the way in revolutionizing the healthcare industry